You have no items in your shopping cart.
On Promotion 
Species Host
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 3276Biotin 715FITC 697HRP 684PE 616APC 450AP 421Cy3 415PerCP 374PE/Cy5 361APC/Cy5.5 360BF405 360BF488 360PE/Cy5.5 360PE/Cy7 360PerCP/Cy5.5 360APC/Cy7 359BF350 358BF555 358BF647 358BF680 358BF700 358BF750 358Cy5 358Cy5.5 358Pacific Blue 358PerCP/Cy7 358RBITC 358BF594 357Cy7 356IRDye800 264AE 75Fluoro488 35Fluoro550 35Fluoro594 35Fluoro647 35RPE 14SureLight 488 6IRDye800CW 2MMAE 1
Biologically Active
Featured Product
Biotinylated Human TRAIL R2 [orb2993682]Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.1 KDa. Observed: 18-25 KDa, reducing conditions
20 μg, 100 μg- Human PDCD5 [orb2994625]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 20 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human PDCD10 [orb2994641]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.9 KDa. Observed: 28 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human BIRC5 [orb2994652]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 16-18 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human FAS [orb2994747]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.7 KDa. Observed: 22-42 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse CD5L [orb2994911]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.43 KDa. Observed: 52 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human PCSK9 [orb2992748]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 71.9 KDa. Observed: (17-21)&(60-70) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human PCSK9 V2 [orb2992796]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 71.9 KDa. Observed: (15-19)&(60-80) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Cynomolgus TNFRSF10B [orb2993089]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18 KDa. Observed: 22-30 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human TRAIL R3 [orb2995031]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 21.78 KDa. Observed: 38-58 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg